- Published at
- by marketscreener.com
mixed
mixed
Allarity Therapeutics Provides Update on Pre-Clinical Testing of Stenoparib's Antiviral Activity Against New Variants of Coronavirus
Press Release ???? ?-Current testing follows preceding pre-clinical tests indicating efficacy of the novel PARP inhibitor stenoparib against SARS-Cov-2, the virus... | February 24, 2021